Czechia· CZ-0271633
SOTYKTU
A deucravacitinib product containing deucravacitinib, registered in Czechia by Bristol-Myers Squibb Pharma EEIG, Dublin. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Deucravacitinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AF07 (deucravacitinib), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Deucravacitinib · ATC L04AF07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of deucravacitinib costs, country by country.
Normalised to the WHO defined daily dose (6 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Deucravacitinib · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- FR France$22.97
The record
At a glance
SÚKL (Czech Republic)- Active substance
- DEUCRAVACITINIB
- Manufacturer
- Bristol-Myers Squibb Pharma EEIG, Dublin
- Country
- Czechia (CZ)
- ATC code
- L04AF07
- ATC class
- Deucravacitinib
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Deucravacitinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSOTYKTUE.R. Squibb & Sons, L.L.C.
- FinlandSOTYKTUBristol-Myers Squibb Pharma EEIG
- FranceSOTYKTU 6 mg, comprimé pelliculéBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- IrelandSOTYKTU 6 mg Film-coated tabletBristol-Myers Squibb Pharma EEIG
- BelgiumSotyktu 6 mgBristol-Myers Squibb Pharma
- NetherlandsSOTYKTU 6 mg filmomhulde tablettenBristol-Myers Squibb Pharma EEIG
- NorwaySotyktuBristol-Myers Squibb Pharma EEIG
- PolandSotyktuBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Sotyktu
- Liechtenstein · Sotyktu
- Norway · Sotyktu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d48c1ae3-4bea-4605-a709-81ce112b7e43 GET /v1/drugs/d48c1ae3-4bea-4605-a709-81ce112b7e43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "6MG",
"pack_size": "7",
"substance": "DEUCRAVACITINIB",
"cz_kod_sukl": "0271633",
"product_type": null,
"substance_codes": "22619",
"registration_state": "R",
"registration_number": "EU/1/23/1718/001"
}See everything about deucravacitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.